Natera
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade Natera 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About NTRA
Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT).
CEOStephen Leonard Chapman
CEOStephen Leonard Chapman
Employees4,434
Employees4,434
HeadquartersAustin, Texas
HeadquartersAustin, Texas
Founded2003
Founded2003
Employees4,434
Employees4,434
NTRA Key Statistics
Market cap22.73B
Market cap22.73B
Price-Earnings ratio-87.10
Price-Earnings ratio-87.10
Dividend yield—
Dividend yield—
Average volume1.59M
Average volume1.59M
High today$166.28
High today$166.28
Low today$161.92
Low today$161.92
Open price$162.89
Open price$162.89
Volume840.22K
Volume840.22K
52 Week high$183.00
52 Week high$183.00
52 Week low$110.57
52 Week low$110.57
NTRA News
Simply Wall St 6d
Natera Reports Positive Phase III Trial Results in Muscle-Invasive Bladder Cancerrecently reported positive topline results from the IMvigor011 clinical trial, demonstrating significant improvements in disease-free and overall survival for p...
Analyst ratings
96%
of 23 ratingsBuy
95.7%
Hold
0%
Sell
4.3%
People also own
Based on the portfolios of people who own NTRA. This list is generated using Robinhood data, and it’s not a recommendation.